Active Follow-up in Patients with Localized Prostate Cancer: Evaluation of Long-term Results
Autor: | S.O. Vozianov, V.M. Grygorenko, R.O. Danylets, A.V. Bardin, L.V. Pereta |
---|---|
Jazyk: | English<br />Ukrainian |
Rok vydání: | 2013 |
Předmět: | |
Zdroj: | Počki, Vol 2, Iss 2.04, Pp 7-10 (2013) |
Druh dokumentu: | article |
ISSN: | 2307-1257 2307-1265 |
DOI: | 10.22141/2307-1257.0.2.04.2013.85343 |
Popis: | Among the clinical recommendations one of the standard approaches in the treatment of prostate cancer is active follow-up. For 13 years, under the supervision there were 85.7 % of patients. Overall 3-, 5- and 7-year survival rate was 93.2 ± 4.6 %, 70.8 ± 9.1 % and 50.9 ± 10.2 %, respectively. 14.3% of patients died due to comorbidities. The average time of survival was 136 months. These data substantiate the feasibility of active follow-up from medical, social and economic point of view. Optimal results can be achieved with the right selection, the criteria of which are: the level of prostate-specific antigen ≤ 10 ng/ml, Gleason grading score ≤ 6, age, multiple organ pathology. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |